Why This Matters GLP-1 receptor agonists do more than help with weight loss.Theyve been shown to: Improve blood sugar control in type 2 diabetes Reduce cardiovascular risk Support long-term metabolic health But for many patients, cost has been a major barrier to starting or staying on therapy.If these new pricing initiatives take effect, more patients could finally access these medications safely and consistently under medical supervision
A meta-analysis of seven SURPASS clinical trials in participants with T2DM showed the hazard ratios comparing tirzepatide versus controls of 0.80 (95% CI, 0.57 1.11) for 4-MACE, 0.90 (95% CI, 0.50 1.61) for cardiovascular death, and 0.80 (95% CI, 0.51 1.25) for all-cause mortality (264)
Hargens, who also sells the patches in addition to using them herself, says she doesnt worry about a conflict of interest
Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
Also, as L carnitine converts long chain fatty acids into energy, fat burning can be achieved through using fat cells as energy rather than muscle cells, helping you maintain lean muscle mass in the process
Is chelation therapy effective for improving blood circulation